455 related articles for article (PubMed ID: 33486006)
1. Frontiers in the treatment of glioblastoma: Past, present and emerging.
Janjua TI; Rewatkar P; Ahmed-Cox A; Saeed I; Mansfeld FM; Kulshreshtha R; Kumeria T; Ziegler DS; Kavallaris M; Mazzieri R; Popat A
Adv Drug Deliv Rev; 2021 Apr; 171():108-138. PubMed ID: 33486006
[TBL] [Abstract][Full Text] [Related]
2. Multi-ligand functionalized blood-to-tumor sequential targeting strategies in the field of glioblastoma nanomedicine.
Martins C; Sarmento B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1893. PubMed ID: 37186374
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
4. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
Gutkin A; Cohen ZR; Peer D
Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
Ganipineni LP; Danhier F; Préat V
J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
[TBL] [Abstract][Full Text] [Related]
6. Translation of focused ultrasound for blood-brain barrier opening in glioma.
Brighi C; Salimova E; de Veer M; Puttick S; Egan G
J Control Release; 2022 May; 345():443-463. PubMed ID: 35337938
[TBL] [Abstract][Full Text] [Related]
7. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
[TBL] [Abstract][Full Text] [Related]
8. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
[TBL] [Abstract][Full Text] [Related]
9. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.
Jena L; McErlean E; McCarthy H
Drug Deliv Transl Res; 2020 Apr; 10(2):304-318. PubMed ID: 31728942
[TBL] [Abstract][Full Text] [Related]
10. Current Challenges and Opportunities in Treating Glioblastoma.
Shergalis A; Bankhead A; Luesakul U; Muangsin N; Neamati N
Pharmacol Rev; 2018 Jul; 70(3):412-445. PubMed ID: 29669750
[TBL] [Abstract][Full Text] [Related]
11. Breaching barriers in glioblastoma. Part II: Targeted drug delivery and lipid nanoparticles.
Miranda A; Blanco-Prieto MJ; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):389-410. PubMed ID: 28801108
[TBL] [Abstract][Full Text] [Related]
12. Therapy for glioblastoma: is it working?
Zanders ED; Svensson F; Bailey DS
Drug Discov Today; 2019 May; 24(5):1193-1201. PubMed ID: 30878561
[TBL] [Abstract][Full Text] [Related]
13. Current State of Immunotherapy for Treatment of Glioblastoma.
McGranahan T; Therkelsen KE; Ahmad S; Nagpal S
Curr Treat Options Oncol; 2019 Feb; 20(3):24. PubMed ID: 30790064
[TBL] [Abstract][Full Text] [Related]
14. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
15. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.
Bastiancich C; Danhier P; Préat V; Danhier F
J Control Release; 2016 Dec; 243():29-42. PubMed ID: 27693428
[TBL] [Abstract][Full Text] [Related]
16. Rationally designed drug delivery systems for the local treatment of resected glioblastoma.
Bastiancich C; Malfanti A; Préat V; Rahman R
Adv Drug Deliv Rev; 2021 Oct; 177():113951. PubMed ID: 34461201
[TBL] [Abstract][Full Text] [Related]
17. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma.
Narsinh KH; Perez E; Haddad AF; Young JS; Savastano L; Villanueva-Meyer JE; Winkler E; de Groot J
Curr Neurol Neurosci Rep; 2024 May; 24(5):123-139. PubMed ID: 38578405
[TBL] [Abstract][Full Text] [Related]
18. Overcoming delivery barriers in immunotherapy for glioblastoma.
Rui Y; Green JJ
Drug Deliv Transl Res; 2021 Dec; 11(6):2302-2316. PubMed ID: 34053034
[TBL] [Abstract][Full Text] [Related]
19.
Gallego L; Ceña V
Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
